Longevity Health Hldgs (XAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,905 | -10,651 | -16,205 | -9,051 | -329 |
| Depreciation Amortization | 215 | 217 | 160 | 2,287 | N/A |
| Accounts receivable | 44 | -4 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 127 | -359 | -450 | 1,060 | N/A |
| Other Working Capital | 2,757 | 1,165 | -3,422 | 2,339 | 16 |
| Other Operating Activity | 433 | 5,738 | 11,569 | -63 | -138 |
| Operating Cash Flow | $-3,329 | $-3,893 | $-8,348 | $-3,429 | $-451 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | N/A | -31 | -7 | N/A |
| Net Acquisitions | -150 | -749 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -154,441 |
| Investing Cash Flow | $-164 | $-749 | $-31 | $-7 | $-154,441 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,860 | 2,746 | 57 |
| Debt Repayment | -441 | -714 | -3,202 | N/A | -55 |
| Common Stock Issued | 4,484 | 2,687 | 41 | 146 | 159,080 |
| Common Stock Repurchased | N/A | N/A | N/A | -2 | N/A |
| Other Financing Activity | 0 | -86 | 12,464 | 662 | -3,416 |
| Financing Cash Flow | $4,043 | $1,887 | $11,163 | $3,552 | $155,666 |
| Beginning Cash Position | 157 | 2,913 | 128 | 12 | N/A |
| End Cash Position | 707 | 157 | 2,913 | 128 | 774 |
| Net Cash Flow | $550 | $-2,755 | $2,784 | $116 | $774 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,329 | -3,893 | -8,348 | -3,429 | -451 |
| Capital Expenditure | -14 | N/A | -31 | -7 | N/A |
| Free Cash Flow | -3,344 | -3,893 | -8,379 | -3,436 | -451 |